News & Updates
Filter by Specialty:
DOAC use persists in NVAF patients with liver disease
A knowledge gap exists on the effects of direct oral anticoagulants (DOACs), but most nonvalvular atrial fibrillation (NVAF) patients with liver disease still begin treatment with these medications, particularly apixaban and rivaroxaban, a study has found.
DOAC use persists in NVAF patients with liver disease
17 Mar 2022
Antihypertensive drugs up risk of psoriasis
Use of antihypertensive medications is associated with the incidence of psoriasis, reports a study. Beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, calcium channel blockers (CCBs), and thiazide diuretics result in an increased risk of psoriasis.
Antihypertensive drugs up risk of psoriasis
17 Mar 2022
Respiratory-gated PET-CT improves liver tumour imaging
A prospective clinical study conducted by the Hong Kong Baptist Hospital in collaboration with the Hong Kong Polytechnic University has demonstrated the feasibility of implementing respiratory-gated PET-CT for liver malignancies with improved image quality compared with ungated scans.
Respiratory-gated PET-CT improves liver tumour imaging
17 Mar 2022
Glycaemic control not a risk factor for cerebral small vessel disease in T1D
Among patients with type 1 diabetes (T1D), medium- and long-term blood glucose control and long-term glycaemic variability do not exert any influence on the risk of developing cerebral small vessel disease, a study has found.